Enanta Pharmaceuticals Inc Banner Image

Enanta Pharmaceuticals Inc

  • Ticker ENTA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Enanta Pharmaceuticals Inc Logo Image
  • 51-200 Employees
  • Based in Watertown, Massachusetts
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the infectious disease field in the United States. Its product portfolio includes ABT-450, a protease inhibitor that is in Phase III clinical trials for the treatment of hepatitis C virus (HCV); ABT-493, a next-generation protease inhibitor for HCV infection; EDP-239, an NS5A inhibitorMore for HCV infection; Cyclophilin inhibitor, which are in preclinical development stage for HCV infection treatment; and Nucleotide Polymerase inhibitor program for HCV infection.
4.8 / 5.0 (280)

Enanta Pharmaceuticals Inc reports have an aggregate usefulness score of 4.8 based on 280 reviews.

Enanta Pharmaceuticals Inc

Most Recent Annual Report

Enanta Pharmaceuticals Inc
MOST RECENT 2022 Annual Report and Form 10K

Enanta Pharmaceuticals Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Enanta Pharmaceuticals Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!